Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO5073031 dose-titration study in type 2 diabetes on metformin
2006-006273-25Phase 2Completed
- Sponsor
- Roche
- Start
- Jan 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of taspoglutide in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Roche. Primary endpoint: Proportion of patients withdrawn because of gastrointestinal adverse events. Started Jan 2007; status: completed.
02
Drugs
taspoglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-006273-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006273-25.